NO20005479D0 - SPLA2-hemmende forbindelser til behandling av sykdom - Google Patents
SPLA2-hemmende forbindelser til behandling av sykdomInfo
- Publication number
- NO20005479D0 NO20005479D0 NO20005479A NO20005479A NO20005479D0 NO 20005479 D0 NO20005479 D0 NO 20005479D0 NO 20005479 A NO20005479 A NO 20005479A NO 20005479 A NO20005479 A NO 20005479A NO 20005479 D0 NO20005479 D0 NO 20005479D0
- Authority
- NO
- Norway
- Prior art keywords
- disease
- treatment
- inhibitory compounds
- spla2
- spla2 inhibitory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8387498P | 1998-05-01 | 1998-05-01 | |
| PCT/US1999/008654 WO1999057100A1 (en) | 1998-05-01 | 1999-04-20 | Spla2 inhibitor compounds for treatment of disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005479D0 true NO20005479D0 (no) | 2000-10-31 |
| NO20005479L NO20005479L (no) | 2000-12-20 |
Family
ID=22181224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005479A NO20005479L (no) | 1998-05-01 | 2000-10-31 | sPLA2-hemmende forbindelser til behandling av sykdom |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6340699B1 (no) |
| EP (1) | EP1084108A4 (no) |
| JP (1) | JP2002513783A (no) |
| KR (1) | KR20010043190A (no) |
| CN (1) | CN1299348A (no) |
| AU (1) | AU3656299A (no) |
| BR (1) | BR9910095A (no) |
| CA (1) | CA2330856A1 (no) |
| CZ (1) | CZ20004052A3 (no) |
| EA (1) | EA200001140A1 (no) |
| HR (1) | HRP20000739A2 (no) |
| HU (1) | HUP0102243A2 (no) |
| ID (1) | ID27153A (no) |
| IL (1) | IL139019A0 (no) |
| NO (1) | NO20005479L (no) |
| PL (1) | PL343708A1 (no) |
| SK (1) | SK16342000A3 (no) |
| TR (1) | TR200003194T2 (no) |
| WO (1) | WO1999057100A1 (no) |
| ZA (1) | ZA200005563B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19962300A1 (de) * | 1999-12-23 | 2001-06-28 | Asta Medica Ag | Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung |
| AU2001236440A1 (en) * | 2000-01-25 | 2001-08-07 | Eli Lilly And Company | Method for the treatment of inflammation with spla2 inhibitors |
| WO2002000621A1 (fr) * | 2000-06-29 | 2002-01-03 | Shionogi & Co., Ltd. | Composes inhibiteurs de la spla2 de type x |
| WO2002007791A2 (en) * | 2000-07-24 | 2002-01-31 | Dow Global Technologies Inc. | Thermoplastic superabsorbent polymer blend compositions and their preparation |
| MX2008005664A (es) * | 2005-11-03 | 2008-12-15 | Ilypsa Inc | Compuestos de indol que tienen sustituyentes c4-acidos y uso de los mismos como inhibidores de fosfolipasa a2. |
| CA2720275A1 (en) * | 2008-04-01 | 2009-10-08 | Astellas Pharma Inc. | Indolinone compound |
| MY198422A (en) | 2009-04-29 | 2023-08-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| US9290752B2 (en) | 2013-03-13 | 2016-03-22 | Sunny Delight Beverages Co. | Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5356919A (en) | 1991-05-30 | 1994-10-18 | G. D. Searle & Co. | Leukotriene B4 synthesis inhibitors |
| DE4218096A1 (de) | 1992-06-02 | 1993-12-09 | Boehringer Mannheim Gmbh | Spiro-oxetane, Verfahren zu ihrer Herstellung und Arzneimittel |
| DE4323409A1 (de) | 1993-07-13 | 1995-01-19 | Boehringer Mannheim Gmbh | Verwendung von Cumarinen und Carbostyrilen als PLA¶2¶-Inhibitoren, neue Cumarine und Carbostyrile, Verfahren zu ihrer Herstellung und Arzneimittel |
| MX9501608A (es) | 1994-04-01 | 1997-02-28 | Lilly Co Eli | 1h-indol-3-glioxilamidas inhibidoras de spla2. |
| WO1995033462A1 (en) * | 1994-06-02 | 1995-12-14 | Smithkline Beecham Corporation | Anti-inflammatory compounds |
| NZ298145A (en) * | 1994-12-29 | 1998-08-26 | Yamanouchi Pharma Co Ltd | Monoclonal antibodies having inhibitory effect on type ii phospholipase a2, proteins forming part thereof, cells producing them, dna encoding them, recombinant vector comprising the dna and medicament |
| PL332896A1 (en) | 1996-10-30 | 1999-10-25 | Lilly Co Eli | Substituted tricyclic compounds |
| CA2322162A1 (en) * | 1998-02-25 | 1999-09-02 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
-
1999
- 1999-04-20 CZ CZ20004052A patent/CZ20004052A3/cs unknown
- 1999-04-20 HU HU0102243A patent/HUP0102243A2/hu unknown
- 1999-04-20 CA CA002330856A patent/CA2330856A1/en not_active Abandoned
- 1999-04-20 TR TR2000/03194T patent/TR200003194T2/xx unknown
- 1999-04-20 ID IDW20002214A patent/ID27153A/id unknown
- 1999-04-20 BR BR9910095-9A patent/BR9910095A/pt not_active Application Discontinuation
- 1999-04-20 EA EA200001140A patent/EA200001140A1/ru unknown
- 1999-04-20 IL IL13901999A patent/IL139019A0/xx unknown
- 1999-04-20 US US09/673,675 patent/US6340699B1/en not_active Expired - Fee Related
- 1999-04-20 SK SK1634-2000A patent/SK16342000A3/sk unknown
- 1999-04-20 AU AU36562/99A patent/AU3656299A/en not_active Abandoned
- 1999-04-20 KR KR1020007012113A patent/KR20010043190A/ko not_active Application Discontinuation
- 1999-04-20 JP JP2000547070A patent/JP2002513783A/ja not_active Withdrawn
- 1999-04-20 EP EP99918711A patent/EP1084108A4/en not_active Withdrawn
- 1999-04-20 CN CN99805675A patent/CN1299348A/zh active Pending
- 1999-04-20 WO PCT/US1999/008654 patent/WO1999057100A1/en not_active Application Discontinuation
- 1999-04-20 PL PL99343708A patent/PL343708A1/xx unknown
-
2000
- 2000-10-10 ZA ZA200005563A patent/ZA200005563B/en unknown
- 2000-10-31 NO NO20005479A patent/NO20005479L/no not_active Application Discontinuation
- 2000-10-31 HR HR20000739A patent/HRP20000739A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK16342000A3 (sk) | 2002-04-04 |
| CA2330856A1 (en) | 1999-11-11 |
| WO1999057100A1 (en) | 1999-11-11 |
| PL343708A1 (en) | 2001-08-27 |
| US6340699B1 (en) | 2002-01-22 |
| EP1084108A4 (en) | 2005-01-12 |
| EA200001140A1 (ru) | 2001-04-23 |
| ID27153A (id) | 2001-03-08 |
| BR9910095A (pt) | 2000-12-26 |
| CN1299348A (zh) | 2001-06-13 |
| EP1084108A1 (en) | 2001-03-21 |
| AU3656299A (en) | 1999-11-23 |
| CZ20004052A3 (cs) | 2002-05-15 |
| TR200003194T2 (tr) | 2001-03-21 |
| ZA200005563B (en) | 2002-01-10 |
| KR20010043190A (ko) | 2001-05-25 |
| NO20005479L (no) | 2000-12-20 |
| IL139019A0 (en) | 2001-11-25 |
| JP2002513783A (ja) | 2002-05-14 |
| HUP0102243A2 (hu) | 2001-10-28 |
| HRP20000739A2 (en) | 2001-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20021474D0 (no) | Forbindelser for behandling av ischemi | |
| NO20005864D0 (no) | Quinasoler til behandling av hjernesvulst | |
| NO20012995L (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
| DK0769947T3 (da) | Indolinonforbindelser til behandling af sygdom | |
| AU2001282873A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
| IL160884A0 (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
| NO20013369D0 (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
| NO20031443L (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
| NO20022087L (no) | Fremgangsmåte for behandling av diabetes | |
| NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
| AU2001284645A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
| NO20026008D0 (no) | Fremgangsmåte for behandling av cardiovaskul¶re sykdommer | |
| NO990722D0 (no) | FremgangsmÕte for behandling av hjertesvikt | |
| NO20013507L (no) | Blandinger for behandling av inflammatoriske reaksjoner | |
| NO20010953D0 (no) | En fremgangsmÕte for behandling av stafylokokkal sykdom | |
| NO20033804L (no) | Karbamatforbindelser for behandling av smerte | |
| ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
| NO20024776D0 (no) | Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte | |
| NO20024777L (no) | Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte | |
| NO20005479D0 (no) | SPLA2-hemmende forbindelser til behandling av sykdom | |
| NO20012612L (no) | Isonipecotamider for behandlingen av integrin-formidlede sykdommer | |
| NO20003481D0 (no) | FremgangsmÕte for behandling av COPD | |
| DK1200447T3 (da) | Oxazinocarbazoler til behandling af CNS-sygdomme | |
| NO20012616D0 (no) | Middel til behandling av erektil malfunksjon | |
| IS2153B (is) | S-nítrósóþíól til meðferðar við blóðrásartruflunum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |